{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:01:53Z","timestamp":1789398113733,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC 012"],"award-info":[{"award-number":["SRC 012"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:59:33Z","timestamp":1674853173000},"page":"275-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-1018","authenticated-orcid":false,"given":"L.R.","family":"Caley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zagoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Duckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Shimmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-1055","authenticated-orcid":false,"given":"A.M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-4028","authenticated-orcid":false,"given":"J.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-1128","authenticated-orcid":false,"given":"J.L.","family":"Whitehouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Floto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Mainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-1868","authenticated-orcid":false,"given":"D.G.","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10059","key":"10.1016\/j.jcf.2023.01.010_bib0001","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2023.01.010_bib0002","unstructured":"Cystic Fibrosis Trust. UK cystic fibrosis registry: 2020 annual data report London 2021 [Available from: https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2021-12\/CF_Annual%20Report%202020_V8.pdf."},{"issue":"127","key":"10.1016\/j.jcf.2023.01.010_bib0003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1183\/09059180.00008412","article-title":"Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"22","author":"Derichs","year":"2013","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10.1016\/j.jcf.2023.01.010_bib0004","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2005.11.006","article-title":"Cystic fibrosis: nutritional consequences and management","volume":"20","author":"Dodge","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.jcf.2023.01.010_bib0005","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/2050640619841545","article-title":"A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders","volume":"7","author":"Hayee","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"9","key":"10.1016\/j.jcf.2023.01.010_bib0006","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2023.01.010_bib0007","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/clinem\/dgac020","article-title":"New concepts in the pathogenesis of cystic fibrosis-related diabetes","volume":"107","author":"Moheet","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2023.01.010_bib0008","article-title":"The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes","volume":"27","author":"Hasan","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2023.01.010_bib0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2018.00020","volume":"9","author":"Kayani","year":"2018","journal-title":"Cystic fibrosis-related diabetes. Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.jcf.2023.01.010_bib0010","article-title":"Cystic fibrosis related diabetes (CFRD) prognosis","volume":"26","author":"Sandouk","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"issue":"2","key":"10.1016\/j.jcf.2023.01.010_bib0011","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2023.01.010_bib0012","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/dc17-1536","article-title":"Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management","volume":"41","author":"Du","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2023.01.010_bib0013","article-title":"Disorders of gastrointestinal motility in diabetes mellitus: an unattended borderline between diabetologists and gastroenterologists","author":"Pal","year":"2021","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jcf.2023.01.010_bib0014","first-page":"333","article-title":"Gastrointestinal complications of cystic fibrosis","volume":"11","author":"Gelfond","year":"2013","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jcf.2023.01.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225004","article-title":"Assessing gastro-intestinal related quality of life in cystic fibrosis: validation of PedsQL GI in children and their parents","volume":"14","author":"Boon","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007418","article-title":"Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis","volume":"5","author":"Abbott","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jcf.2023.01.010_bib0018","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1572-0241.2001.03350.x","article-title":"Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life","volume":"96","author":"Talley","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0019","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jcf.2016.05.009","article-title":"Pancreatic Elastase-1 Quick Test for rapid assessment of pancreatic status in cystic fibrosis patients","volume":"15","author":"Walkowiak","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2023.01.010_bib0020","doi-asserted-by":"crossref","first-page":"17465","DOI":"10.1038\/s41598-017-17302-4","article-title":"Relation of ultrasound findings and abdominal symptoms obtained with the CFAbd-score in cystic fibrosis patients","volume":"7","author":"Tabori","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jcf.2023.01.010_bib0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40271-019-00361-2","article-title":"Validity and reliability of a novel multimodal questionnaire for the assessment of abdominal symptoms in people with cystic fibrosis (CFAbd-Score)","volume":"12","author":"Jaudszus","year":"2019","journal-title":"Patient"},{"key":"10.1016\/j.jcf.2023.01.010_bib0022","unstructured":"U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for devices and radiological health (CDRH),. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims 2009 [Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims."},{"issue":"1","key":"10.1016\/j.jcf.2023.01.010_bib0023","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc: Ser B (Methodol)"},{"issue":"8","key":"10.1016\/j.jcf.2023.01.010_bib0024","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","article-title":"False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies","volume":"67","author":"Glickman","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcf.2023.01.010_bib0025","unstructured":"R Core Team. R: a language and environment for statistical computing Vienna: Austria: R foundation for statistical computing; 2022 [Available from: https:\/\/www.R-project.org\/."},{"issue":"4","key":"10.1016\/j.jcf.2023.01.010_bib0026","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.01.010_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.877118","article-title":"Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-score","volume":"13","author":"Mainz","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jcf.2023.01.010_bib0028","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPG.0000000000003357","article-title":"Abdominal symptoms assessed with the CFAbd-score are associated with intestinal inflammation in patients with cystic fibrosis","volume":"74","author":"Jaudszus","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2023.01.010_bib0029","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/S1569-1993(22)00376-9","article-title":"P043 Significant reduction in abdominal symptoms assessed with the CFAbd-Score over 6 months of elexacaftor\/tezacaftor\/ivacaftor (ETI) - follow-up results from Irish and British cystic fibrosis patients (RECOVER study)","volume":"21","author":"Mainz","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2023.01.010_bib0030","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","article-title":"Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule","volume":"58","author":"Gelfond","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0031","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/adc.82.5.394","article-title":"Intestinal inflammation in cystic fibrosis","volume":"82","author":"Smyth","year":"2000","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.jcf.2023.01.010_bib0032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The altered gut microbiota in adults with cystic fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiol"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0033","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/joim.12910","article-title":"Mucus and mucins in diseases of the intestinal and respiratory tracts","volume":"285","author":"Hansson","year":"2019","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.jcf.2023.01.010_bib0034","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcf.2021.12.007","article-title":"Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls","volume":"21","author":"Dellschaft","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40271-017-0233-0","article-title":"Qualitative assessment of the symptoms and impact of pancreatic exocrine insufficiency (PEI) to inform the development of a patient-reported outcome (PRO) instrument","volume":"10","author":"Johnson","year":"2017","journal-title":"Patient"},{"issue":"5","key":"10.1016\/j.jcf.2023.01.010_bib0036","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.chest.2016.11.009","article-title":"Cystic fibrosis and the nervous system","volume":"151","author":"Reznikov","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jcf.2023.01.010_bib0037","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MPG.0b013e31802c0ceb","article-title":"Risk factors for small bowel bacterial overgrowth in cystic fibrosis","volume":"44","author":"Fridge","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:47:58Z","timestamp":1761601678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1569199323000188"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.01.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}